Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene

Hdl Handle:
http://hdl.handle.net/10147/215140
Title:
Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene
Authors:
Meehan, Maria; Parthasarathi, Laavanya; Moran, Niamh; Jefferies, Caroline A; Foley, Niamh; Lazzari, Elisa; Murphy, Derek; Ryan, Jacqueline; Ortiz, Berenice; Fabius, Armida W M; Chan, Timothy A; Stallings, Raymond L
Citation:
Molecular Cancer. 2012 Feb 05;11(1):6
Issue Date:
5-Feb-2012
URI:
http://hdl.handle.net/10147/215140
Abstract:
Abstract Background Protein tyrosine phosphatase receptor delta (PTPRD) is a member of a large family of protein tyrosine phosphatases which negatively regulate tyrosine phosphorylation. Neuroblastoma is a major childhood cancer arising from precursor cells of the sympathetic nervous system which is known to acquire deletions and alterations in the expression patterns of PTPRD, indicating a potential tumor suppressor function for this gene. The molecular mechanism, however, by which PTPRD renders a tumor suppressor effect in neuroblastoma is unknown. Results As a molecular mechanism, we demonstrate that PTPRD interacts with aurora kinase A (AURKA), an oncogenic protein that is over-expressed in multiple forms of cancer, including neuroblastoma. Ectopic up-regulation of PTPRD in neuroblastoma dephosphorylates tyrosine residues in AURKA resulting in a destabilization of this protein culminating in interfering with one of AURKA's primary functions in neuroblastoma, the stabilization of MYCN protein, the gene of which is amplified in approximately 25 to 30% of high risk neuroblastoma. Conclusions PTPRD has a tumor suppressor function in neuroblastoma through AURKA dephosphorylation and destabilization and a downstream destabilization of MYCN protein, representing a novel mechanism for the function of PTPRD in neuroblastoma.
Item Type:
Journal Article

Full metadata record

DC FieldValue Language
dc.contributor.authorMeehan, Maria-
dc.contributor.authorParthasarathi, Laavanya-
dc.contributor.authorMoran, Niamh-
dc.contributor.authorJefferies, Caroline A-
dc.contributor.authorFoley, Niamh-
dc.contributor.authorLazzari, Elisa-
dc.contributor.authorMurphy, Derek-
dc.contributor.authorRyan, Jacqueline-
dc.contributor.authorOrtiz, Berenice-
dc.contributor.authorFabius, Armida W M-
dc.contributor.authorChan, Timothy A-
dc.contributor.authorStallings, Raymond L-
dc.date.accessioned2012-03-09T14:30:30Z-
dc.date.available2012-03-09T14:30:30Z-
dc.date.issued2012-02-05-
dc.identifierhttp://dx.doi.org/10.1186/1476-4598-11-6-
dc.identifier.citationMolecular Cancer. 2012 Feb 05;11(1):6-
dc.identifier.urihttp://hdl.handle.net/10147/215140-
dc.description.abstractAbstract Background Protein tyrosine phosphatase receptor delta (PTPRD) is a member of a large family of protein tyrosine phosphatases which negatively regulate tyrosine phosphorylation. Neuroblastoma is a major childhood cancer arising from precursor cells of the sympathetic nervous system which is known to acquire deletions and alterations in the expression patterns of PTPRD, indicating a potential tumor suppressor function for this gene. The molecular mechanism, however, by which PTPRD renders a tumor suppressor effect in neuroblastoma is unknown. Results As a molecular mechanism, we demonstrate that PTPRD interacts with aurora kinase A (AURKA), an oncogenic protein that is over-expressed in multiple forms of cancer, including neuroblastoma. Ectopic up-regulation of PTPRD in neuroblastoma dephosphorylates tyrosine residues in AURKA resulting in a destabilization of this protein culminating in interfering with one of AURKA's primary functions in neuroblastoma, the stabilization of MYCN protein, the gene of which is amplified in approximately 25 to 30% of high risk neuroblastoma. Conclusions PTPRD has a tumor suppressor function in neuroblastoma through AURKA dephosphorylation and destabilization and a downstream destabilization of MYCN protein, representing a novel mechanism for the function of PTPRD in neuroblastoma.-
dc.titleProtein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene-
dc.typeJournal Article-
dc.language.rfc3066en-
dc.rights.holderMeehan et al.; licensee BioMed Central Ltd.-
dc.description.statusPeer Reviewed-
dc.date.updated2012-02-29T12:04:22Z-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.